Randomized Double-Blind Phase III Study to Evaluate Patients with Nonalcoholic Steatohepatitis (NASH) and fibrosis

July 31, 2018
https://clinicaltrials.gov/ct2/show/NCT02704403
Gastroenterology Hepatology
Principal Investigator: Stuart C Gordon, MD
NASH, Liver Disease,Nonalcoholic Steatohepatitis (NASH) and fibrosis, Fatty Liver
Open